Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.96% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
NKTR · Dec 31, 2023
NEKTAR THERAPEUTICS. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-026249General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-213.72% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
17.87% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
62.53% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-292.59% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
126.67% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
37.05% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History12 statesHistory building
Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/7 normalizedLevel 3Jun 30, 20240/7 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Dec 31, 20240/8 normalizedLevel 3Mar 31, 20250/7 normalizedLevel 3Jun 30, 20250/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/8 normalizedLevel 3Mar 31, 20265/6 normalizedLevel 3Jun 30, 20265/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.14%
- Current
- 0.96%
- Delta
- 0.82%
- Previous
- -174.46%
- Current
- -213.72%
- Delta
- -39.26%
- Previous
- 62.67%
- Current
- 17.87%
- Delta
- -44.80%
- Previous
- 48.51%
- Current
- 62.53%
- Delta
- 14.02%
- Previous
- -185.82%
- Current
- -292.59%
- Delta
- -106.77%
- Previous
- 99.69%
- Current
- 126.67%
- Delta
- 26.98%
- Previous
- 33.75%
- Current
- 37.05%
- Delta
- 3.30%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · NKTR Fundamental State →Has State · NEKTAR THERAPEUTICS →Transitioned To · NKTR Fundamental State →Transitioned To · NKTR CAPEX_INTENSITY_INCREASED →Transitioned To · NKTR CASH_GENERATION_DECREASED →Transitioned To · NKTR INVENTORY_PRESSURE_DECREASED →Transitioned To · NKTR MARGIN_INCREASED →Transitioned To · NKTR PROFITABILITY_DECREASED →Transitioned To · NKTR R_AND_D_INTENSITY_INCREASED →Transitioned To · NKTR SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.